Good morning, everyone, and welcome back. How was the weekend? Ours was quite hectic, but we hope yours was refreshing and invigorating. Now, though, the routine of meetings and deadlines has resumed. And, of course, one must brace for unexpected developments. And these will occur. So, as usual, we are fortifying ourselves with a cup or two of stimulation and invite you to join us. Meanwhile, here are some tidbits. Hope your day goes well and do stay in touch...
Teva Stock Jumps After Copaxane Patents Are Upheld (Reuters)
Shire Stock Dives After FDA OKs Acatavis Version Of Adderall XR (Bloomberg News)
European Drugmakers Seek Deal On Euro Crisis Pricing (Wall Street Journal)
NHS Complains That Pharma Rationing Causes Risky Shortages (The Telepgraph)
Indian Drugmakers Refuse To Disclose Pricing Info (Hindustan Times)
Wisconsin Court Upholds Rx Inflation Pricing Ruling (State Bar)
McKesson Can Be Sued For Distributing NuvaRing (Legal Examiner)
EDITOR'S NOTE: Please check this post for updates during the day
sunrise pic thx to benimoto on flickr
1 Comment